Last reviewed · How we verify
Oral Non-Beta-Lactam Antibiotic
Oral Non-Beta-Lactam Antibiotic is a Small molecule drug developed by Michael Garron Hospital. It is currently FDA-approved.
At a glance
| Generic name | Oral Non-Beta-Lactam Antibiotic |
|---|---|
| Sponsor | Michael Garron Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Oral Antibiotics For Bone Infections of the Leg and Foot (PHASE4)
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial (PHASE2)
- Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP (PHASE4)
- A Platform Trial for Gram Negative Bloodstream Infections (NA)
- Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward (PHASE3)
- Early Antibiotics After Aspiration in ICU Patients (PHASE4)
- Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care (PHASE4)
- Staphylococcus Aureus Network Adaptive Platform Trial (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oral Non-Beta-Lactam Antibiotic CI brief — competitive landscape report
- Oral Non-Beta-Lactam Antibiotic updates RSS · CI watch RSS
- Michael Garron Hospital portfolio CI
Frequently asked questions about Oral Non-Beta-Lactam Antibiotic
What is Oral Non-Beta-Lactam Antibiotic?
Oral Non-Beta-Lactam Antibiotic is a Small molecule drug developed by Michael Garron Hospital.
Who makes Oral Non-Beta-Lactam Antibiotic?
Oral Non-Beta-Lactam Antibiotic is developed and marketed by Michael Garron Hospital (see full Michael Garron Hospital pipeline at /company/michael-garron-hospital).
What development phase is Oral Non-Beta-Lactam Antibiotic in?
Oral Non-Beta-Lactam Antibiotic is FDA-approved (marketed).